Literature DB >> 19721345

[Th17 cells in human rheumatoid arthritis].

Hisakata Yamada1.   

Abstract

Many autoimmune diseases, such as rheumatoid arthritis (RA), have been thought as Th1-mediated diseases. However, recent studies demonstrated critical roles of IL-17, which is produced by a newly identified subset of helper CD4T cells, Th17, in the development of murine models of autoimmune diseases. In addition, many biological functions of IL-17 fit very well with the pathology of RA joints. However, despite the presence of some reports detecting IL-17 in RA joints, the prevalence of Th17 cells in human RA had been largely unknown. Therefore, we analyzed Th17 cells in RA by intracellular staining methods. We found the frequency of IL-17-producing T cells was not increased in RA and was not correlated with disease activity of RA. Surprisingly, the frequency of CD4 T cells capable of IL-17 was decreased in the joints compared with PBL in each individual, whereas Th1 cells predominantly infiltrated in the joints. Taken together with the results of other reports measuring IL-17 production in RA, it seems premature to conclude that IL-17 is abundantly produced in RA joints. Further investigation on the involvement of Th17/IL-17 in human RA is required.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19721345     DOI: 10.2177/jsci.32.249

Source DB:  PubMed          Journal:  Nihon Rinsho Meneki Gakkai Kaishi        ISSN: 0911-4300


  2 in total

1.  Autophagy impacts on oxaliplatin-induced hepatocarcinoma apoptosis via the IL-17/IL-17R-JAK2/STAT3 signaling pathway.

Authors:  Jinghua Wu; Jiapei Guo; Qing Cao; Yi Wang; Junmao Chen; Zhigang Wang; Zhiyong Yuan
Journal:  Oncol Lett       Date:  2016-12-08       Impact factor: 2.967

2.  The accumulation and prognosis value of tumor infiltrating IL-17 producing cells in esophageal squamous cell carcinoma.

Authors:  Lin Lv; Ke Pan; Xiao-dong Li; Ke-lin She; Jing-jing Zhao; Wei Wang; Ju-gao Chen; Yi-bin Chen; Jing-ping Yun; Jian-chuan Xia
Journal:  PLoS One       Date:  2011-03-31       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.